Ridge Biotechnologies
Palo Alto, California, United States
Ridge Bio is a healthcare startup focused on catalyzing the next generation of precision medicines through AI-driven enzyme and targeted drug design. The company's proprietary platform utilizes machine learning models informed by extensive cell-free datasets to design precision enzymes and targeted delivery systems with unprecedented speed and scale. Ridge Bio offers product lines including NativeLink TM for precision conjugation, ProTrigger TM for targeted therapies, and catalytic medicines aimed at developing novel enzyme-based therapeutics for challenging drug targets. By enhancing the development of safer and more effective medicines, Ridge Bio is positioned at the forefront of bioconjugate innovation and therapeutic advancements.
Company Info
- Founded
- 2024
- Website
- ridgebio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Ridge Biotechnologies?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.